[go: up one dir, main page]

DK155491D0 - Behandling af patienter med kronisk leversygdom - Google Patents

Behandling af patienter med kronisk leversygdom

Info

Publication number
DK155491D0
DK155491D0 DK911554A DK155491A DK155491D0 DK 155491 D0 DK155491 D0 DK 155491D0 DK 911554 A DK911554 A DK 911554A DK 155491 A DK155491 A DK 155491A DK 155491 D0 DK155491 D0 DK 155491D0
Authority
DK
Denmark
Prior art keywords
patients
pct
treatment
chronic health
health disease
Prior art date
Application number
DK911554A
Other languages
Danish (da)
English (en)
Inventor
Niels Erik Skakkebaek
Soeren Moeller
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US08/199,319 priority Critical patent/US5492891A/en
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK911554A priority patent/DK155491D0/da
Publication of DK155491D0 publication Critical patent/DK155491D0/da
Priority to EP92919793A priority patent/EP0602172B1/en
Priority to PCT/DK1992/000245 priority patent/WO1993004694A1/en
Priority to CA002116535A priority patent/CA2116535C/en
Priority to DK92919793T priority patent/DK0602172T3/da
Priority to AT92919793T priority patent/ATE192656T1/de
Priority to JP05504838A priority patent/JP3105541B2/ja
Priority to ES92919793T priority patent/ES2148180T3/es
Priority to AU25798/92A priority patent/AU664201B2/en
Priority to DE69231036T priority patent/DE69231036T2/de
Priority to GR20000401793T priority patent/GR3034096T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrotherapy Devices (AREA)
DK911554A 1991-09-05 1991-09-05 Behandling af patienter med kronisk leversygdom DK155491D0 (da)

Priority Applications (12)

Application Number Priority Date Filing Date Title
US08/199,319 US5492891A (en) 1991-09-05 1991-08-18 Method for treatment of patients with chronic liver disease
DK911554A DK155491D0 (da) 1991-09-05 1991-09-05 Behandling af patienter med kronisk leversygdom
DE69231036T DE69231036T2 (de) 1991-09-05 1992-08-18 Verfahren zur behandlung von patienten mit chronischer lebererkrankung
CA002116535A CA2116535C (en) 1991-09-05 1992-08-18 A method for treatment of patients with chronic liver disease
PCT/DK1992/000245 WO1993004694A1 (en) 1991-09-05 1992-08-18 A method for treatment of patients with chronic liver disease
EP92919793A EP0602172B1 (en) 1991-09-05 1992-08-18 A method for treatment of patients with chronic liver disease
DK92919793T DK0602172T3 (da) 1991-09-05 1992-08-18 Metode til behandling af patienter med kronisk leversygdom
AT92919793T ATE192656T1 (de) 1991-09-05 1992-08-18 Verfahren zur behandlung von patienten mit chronischer lebererkrankung
JP05504838A JP3105541B2 (ja) 1991-09-05 1992-08-18 慢性肝疾患治療剤
ES92919793T ES2148180T3 (es) 1991-09-05 1992-08-18 Metodo para el tratamiento de pacientes con enfermedades hepaticas cronicas.
AU25798/92A AU664201B2 (en) 1991-09-05 1992-08-18 A method for treatment of patients with chronic liver disease
GR20000401793T GR3034096T3 (en) 1991-09-05 2000-08-02 A method for treatment of patients with chronic liver disease.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK911554A DK155491D0 (da) 1991-09-05 1991-09-05 Behandling af patienter med kronisk leversygdom

Publications (1)

Publication Number Publication Date
DK155491D0 true DK155491D0 (da) 1991-09-05

Family

ID=8106016

Family Applications (2)

Application Number Title Priority Date Filing Date
DK911554A DK155491D0 (da) 1991-09-05 1991-09-05 Behandling af patienter med kronisk leversygdom
DK92919793T DK0602172T3 (da) 1991-09-05 1992-08-18 Metode til behandling af patienter med kronisk leversygdom

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK92919793T DK0602172T3 (da) 1991-09-05 1992-08-18 Metode til behandling af patienter med kronisk leversygdom

Country Status (11)

Country Link
US (1) US5492891A (es)
EP (1) EP0602172B1 (es)
JP (1) JP3105541B2 (es)
AT (1) ATE192656T1 (es)
AU (1) AU664201B2 (es)
CA (1) CA2116535C (es)
DE (1) DE69231036T2 (es)
DK (2) DK155491D0 (es)
ES (1) ES2148180T3 (es)
GR (1) GR3034096T3 (es)
WO (1) WO1993004694A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9401045A (nl) * 1994-03-15 1995-10-02 Leuven K U Res & Dev Nieuw gebruik van groeihormoon.
AU1942995A (en) * 1994-03-15 1995-10-03 K.U. Leuven Research & Development New use of growth hormone
US5705482A (en) * 1995-01-13 1998-01-06 Novo Nordisk A/S Pharmaceutical formulation
JP3869874B2 (ja) * 1995-11-15 2007-01-17 大日本住友製薬株式会社 急性肝不全治療剤
ES2146530B1 (es) * 1997-12-26 2001-04-16 Consejo Superior Investigacion Utilizacion del factor de crecimiento igf-i en la fabricacion de composiciones utiles en el tratamiento de la ataxia cerebelar.
RU2204399C1 (ru) * 2001-12-29 2003-05-20 Челябинский государственный институт лазерной хирургии Способ патогенетического лечения хронических заболеваний печени в эксперименте
RU2203675C1 (ru) * 2001-12-29 2003-05-10 Челябинский государственный институт лазерной хирургии Способ патогенетической терапии хронических заболеваний печени
CA2495395C (en) * 2002-06-20 2013-01-08 Bionethos Holding Gmbh Method and device for multiplying and differentiating cells in the presence of growth factors and of a biological matrix or of a supporting structure
MXPA05004384A (es) 2002-10-23 2005-10-18 Johnson & Johnson Piperacinil y diacepanil benzamidas y benztioamidas.
BRPI0409877A (pt) * 2003-04-30 2006-05-16 Kanga Kenji Wa agentes preventivos ou remédios para doenças hepáticas
EP1574211A1 (en) 2004-03-09 2005-09-14 Inserm Use of antagonists of the CB1 receptor for the manufacture of a composition useful for the treatment of hepatic diseases
RU2333020C1 (ru) * 2007-04-05 2008-09-10 Государственное образовательное учреждение дополнительного профессионального образования "Новокузнецкий государственный институт усовершенствования врачей Федерального агентства по здравоохранению и социальному развитию" Способ реабилитации больных с постхолецистэктомическим синдромом

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4898857A (en) * 1984-10-29 1990-02-06 Chaovanee Aroonsakul Treating control nervous system diseases
US5096885A (en) * 1988-04-15 1992-03-17 Genentech, Inc. Human growth hormone formulation
WO1991011195A1 (en) * 1990-02-02 1991-08-08 Novo Nordisk A/S A method of treating a mammal with a biologically active compound

Also Published As

Publication number Publication date
US5492891A (en) 1996-02-20
EP0602172B1 (en) 2000-05-10
DK0602172T3 (da) 2000-10-02
JP3105541B2 (ja) 2000-11-06
AU2579892A (en) 1993-04-05
JPH06510292A (ja) 1994-11-17
DE69231036D1 (de) 2000-06-15
GR3034096T3 (en) 2000-11-30
ATE192656T1 (de) 2000-05-15
CA2116535C (en) 2000-10-31
ES2148180T3 (es) 2000-10-16
EP0602172A1 (en) 1994-06-22
DE69231036T2 (de) 2000-11-02
WO1993004694A1 (en) 1993-03-18
CA2116535A1 (en) 1993-03-18
AU664201B2 (en) 1995-11-09

Similar Documents

Publication Publication Date Title
ATE151292T1 (de) Förderung des hepatozytwachstums mit hepatozytwachstumsfaktor und gamma-interferon
DK155491D0 (da) Behandling af patienter med kronisk leversygdom
DE69132688D1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
DE69230112D1 (de) Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin
DK1808438T3 (da) Rensning og stabilisering af peptid og proteiner i lægemidler
ATE481970T1 (de) Zusammensetzungen enthaltend capsaicin oder capsaicin analoge und ein anästhetikum
ATE94877T1 (de) Piperazinylderivate von purinen und deren isostere als hypoglykaemische wirkstoffe.
DK0777483T3 (da) Fremgangsmåder og middel til lægemiddelindgivelse
DE69400799D1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
SE9201573D0 (sv) Use of igf-1
DE69226835D1 (de) Verfahren und zusammensetzungen zur behandlung von diabetes mellitus, hypoglykämie und anderer krankhafter zustände
IL161889A0 (en) Method for treating diseases with omega interferon
NO882853D0 (no) Korreksjon med dobbeltraadet rna av unormale tilstander i immunkomplekser som er i omloep, og i monocytfunkjon.
ATE201598T1 (de) Verwendung von moxonidin zur behandlung neuropathischer schmerzen
DE60130798D1 (de) "alpha1-untereinheit des natriumkanals, polypeptide davon und deren verwendung zur behandlung von generalisierter epilepsie mit fieberanfällen plus "
ATE203511T1 (de) Selektive beta3-adrenergische agonisten
DK0651648T3 (da) Farmaceutisk præparat indeholdende IL-6. Anvendelse deraf til behandling af konsumptiv trombo-hæmoragisk sygdom
NO960866D0 (no) Fremgangsmåte til behandling av leversykdom og lignende indikasjoner med vasodilaterende midler
DE60019166D1 (de) Verwendung von adatanserin zur behandlung von akuten neurodegenerativen erkrankungen
DE60121449D1 (de) Behandlung von hepatitis c mit thymosin und pegyliertem interferon

Legal Events

Date Code Title Description
ATS Application withdrawn
PBP Patent lapsed